By Hanna Vioque ( November 5, 2026, 6:38 PM GMT) -- Fresenius has lost a patent over a biosimilar version of a blockbuster arthritis drug, after European officials ruled that scientists at the time would have arrived at its claimed formula by making an obvious adjustment to an existing composition. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.